Biothera, Ortho Molecular Partner for Immune Health

Immune health company Biothera has partnered with Ortho Molecular Products to debut Biothera's Wellmune WGP® in the healthcare professional market.

January 6, 2014

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

EAGEN, Minn.Immune health company Biothera has partnered with Ortho Molecular Products to debut Biothera's Wellmune WGP® in the healthcare professional market. Ortho Molecular Products launched its WholeMune capsules containing Wellmune, including a 10-count blister pack.

Biothera is a respected leader in immune research and we are excited to partner with them," said Aaron Bartz, president of Ortho Molecular Products. "Wellmunes extensive clinical research underscores its effectiveness and meets our demand for ingredients that have proven resultsbecause we are committed to providing efficacious products that get patients better faster."

 WholeMune contains the recommended 250 mg of Wellmune, a proprietary strain of baker's yeast. The 1,3/1,6 beta glucan is clinically proven to maintain health during the cold and flu season.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like